Analyst Research Report Snapshot

Title:

UPDATE: Aurobindo Pharma receives its 150th final ANDA approval for Levofloxacin Injection

Price:

$5.00

Provider:

News Bites Pty Limited

Date:

25 Jan 2013

Pages:

14

Type:

AcrobatPDF

Companies referenced:

ARBN.NS

Available for Immediate Download
Summary:

Aurobindo Pharma Ltd (AUROPHARMA), India's 15th largest pharmaceuticals company by market capitalisation, added Rs4.10 (or 2.2%) to close at Rs187.60, ending a three-day streak of losses. Compared with the BSE Sensex Index, which rose 202.8 points (or 1.0%) on the day, this was a relative price c...

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.